Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population

다국어 초록 (Multilingual Abstract)

Paraoxonase 1 (PON1) hydrolyzes a number of toxic organophosphorous compounds and reduces lipid peroxide accumulation, and PON1 genetic polymorphisms in the coding region modulate serum PON1 activity. In this study, we investigated the association between 3 polymorphisms of PON1 located in intron 5 (17899insdelTT and 17974CT) and exon 6 (192QR) and serum PON1 activity. The genetic polymorphisms and serum activity of PON1 were analyzed in 153 healthy Koreans by using a direct sequencing assay and spectrophotometric method, respectively. A significant linkage disequilibrium (LD) was observed between all tested single nucleotide polymorphisms, with the strongest LD observed between 17899insdelTT and 192QR (D’ = 0.984). The 17899insdelTT, 17974CT and 192QR genetic polymorphisms were associated with significant differences in serum paraoxonase activity. In multiple regression analyses, smoking, triglyceride level, highdensity lipoprotein (HDL) level, and the 17899insdelTT and 192QR genetic polymorphisms were significant determinants of serum paraoxonase activity, while age, smoking,triglyceride level, HDL level, and the 192QR genetic polymorphism were significant determinants of serum arylesterase activity. These results suggest that although the 192QR genetic polymorphism in the coding region of PON1 is primarily associated with serum PON1 activity, the intronic polymorphisms are also involved in serum PON1 activity, and this association may be mediated by LD.

참고문헌 (Reference)

1 이철호, "다환성 방향족 탄화수소 노출에 의한 DNA 산화적 손상과 paraoxonase-1 (PON1) 유전자 다형성이 폐암 발생에 미치는 영향" 대한예방의학회 38 (38): 345-350, 2005

2 James RW, "The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity" 37 : 1986-1994, 2004

3 Primo-Parmo SL, "The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family" 33 : 498-507, 1996

4 Eckerson HW, "The human serum paraoxonase/ arylesterase polymorphism" 35 : 1126-1138, 1983

5 Bhattacharyya T, "Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk" 299 : 1265-1276, 2008

6 Davis KA, "Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners" 117 : 1226-1231, 2009

7 Wang X, "Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map" 22 : 1390-1401, 2002

8 Mackness MI, "Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase" 104 : 129-135, 1993

9 Ng CJ, "Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein" 276 : 44444-44449, 2001

10 Mackness MI, "Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein" 286 : 152-154, 1991

11 신병수, "Paraoxonase Gene Polymorphism in South-western Korean Population" 대한의학회 24 (24): 561-566, 2009

12 Richter RJ, "Paraoxonase 1 (PON1) status and substrate hydrolysis" 235 : 1-9, 2009

13 Hugo H, "Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers" 45 : 1143-1154, 2006

14 Costa LG, "Modulation of paraoxonase (PON1) activity" 69 : 541-550, 2005

15 Baralle M, "Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing" 83 : 77-88, 2008

16 Chen J, "Increased influence of genetic variation on PON1 activity in neonates" 111 : 1403-1409, 2003

17 Hong SH, "Genetic variations of the paraoxonase gene in patients with coronary artery disease" 34 : 475-481, 2001

18 Furlong CE, "Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1)" 21 : 91-100, 2000

19 Deakin SP, "Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase- 1" 107 : 435-447, 2004

20 Wang X, "Genetic and environmental factors associated with plasma paraoxonase activity in healthy Chinese" 13 : 445-450, 2004

21 La Du BN, "Future studies of low-activity PON1 phenotype subjects may reveal how PON1 protects against cardiovascular disease" 23 : 1317-1318, 2003

22 Costa LG, "Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism" 54 : 371-392, 2003

23 Wang X, "Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population" 23 : 328-334, 2003

24 Solak ZA, "Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people" 5 : 99-105, 2005

25 Muráni E, "Dual effect of a single nucleotide polymorphism in the first intron of the porcine secreted phosphoprotein 1 gene: allele-specific binding of C/EBP beta and activation of aberrant splicing" 10 : 96-, 2009

26 Richter RJ, "Determination of paraoxonase (PON1) status requires more than genotyping" 9 : 745-753, 1999

27 Rainwater DL, "Determinants of variation in human serum paraoxonase activity" 102 : 147-154, 2009

28 Nishio E, "Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols" 236 : 289-293, 1997

29 Yamada Y, "Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese" 48 : 469-475, 2003

30 Lee CH, "8-hydroxydeoxyguanosine levels in human leukocyte and urine according to exposure to organophosphorus pesticides and paraoxonase 1 genotype" SPRINGER-VERLAG 80 (80): 217-227, 2007